PECAM1 and neoplasm: To validate the in vivo optoacoustic findings and evaluate the effects of Taxotere treatment on tumor vasculature and hypoxia to a greater detail, we conducted immunohistochemical analysis using the endothelial marker CD31 and two hypoxia markers (pimonidazole, CA9).